Is Okta Stock Finally Gaining Investor Confidence?
Given how digital transformation has proliferated, cyberattacks have also been…
Buy
70
AKESF Quote, Financials, Valuation and Earnings
Last price:
$11.30
Seasonality move
:
-24.84%
Day range:
$11.30 - $13.00
52-week range:
$4.30 - $14.13
Dividend yield:
0%
P/E ratio:
18.19x
P/S ratio:
33.58x
P/B ratio:
11.20x
Volume:
17.7K
Avg. volume:
9.4K
1-year change:
84.34%
Market cap:
$10.5B
Revenue:
$296M
EPS (TTM):
-$0.12
Analysts' Opinion
-
Consensus RatingNo consensus rating exists at this time due to lack of analyst coverage.
-
Price Target DownsideNo price target exists because of limited analyst coverage.
-
Price Target UpsideSimilarly, at this time, analysts have not provided a price target so downside risk can't be assessed accurately at this time.
Fair Value
-
According to the consensus of 0 analysts, Akeso has -- downside to fair value with a price target of -- per share.
AKESF vs. S&P 500
-
Over the past 5 trading days, Akeso has overperformed the S&P 500 by 5.72% suggesting its relative strength compared to the major market average is strong at this time.
Share Buyback
-
Akeso does not have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.
Revenue Growth
-
Akeso has grown year-over-year revenues for 0 quarters straight. In the most recent quarter Akeso reported revenues of --.
Earnings Growth
-
Akeso has grown year-over-year earnings for 0 quarters straight. In the most recent quarter Akeso reported earnings per share of --.
Enterprise value:
10B
EV / Invested capital:
--
Price / LTM sales:
33.58x
EV / EBIT:
17.76x
EV / Revenue:
33.81x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-136.10x
Price / Operating cash flow:
23.02x
Enterprise value / EBITDA:
16.61x
Gross Profit (TTM):
$241.3M
Return On Assets:
-7.71%
Net Income Margin (TTM):
-39.23%
Return On Equity:
-15.02%
Return On Invested Capital:
-9.4%
Operating Margin:
--
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2024-04-30 | |||
| Income Statement | ||||||
| Revenue | -- | -- | -- | -- | -- | |
| Gross Profit | -- | -- | -- | -- | -- | |
| Operating Income | -- | -- | -- | -- | -- | |
| EBITDA | -- | -- | -- | -- | -- | |
| Diluted EPS | -- | -- | -- | -- | -- | |
| Period Ending | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 2024-12-31 | |
|---|---|---|---|---|---|---|
| Balance Sheet | ||||||
| Current Assets | $459.4M | $494.5M | $443.3M | $800.8M | $1.2B | |
| Total Assets | $590.2M | $754M | $796.6M | $1.3B | $1.7B | |
| Current Liabilities | $26M | $102.9M | $197.3M | $169.9M | $231M | |
| Total Liabilities | $62.1M | $239.3M | $427.3M | $657.7M | $822.1M | |
| Total Equity | $528.1M | $514.6M | $369.3M | $637.5M | $925.1M | |
| Total Debt | $29.5M | $133.2M | $270.6M | $418.7M | $539.9M | |
| Trailing 12 Months | Fiscal Quarters | |||||
|---|---|---|---|---|---|---|
| Period Ending | 2023-04-30 | 2024-04-30 | 2024-04-30 | |||
| Cash Flow Statement | ||||||
| Cash Flow Operations | -- | -- | -- | -- | -- | |
| Cash From Investing | -- | -- | -- | -- | -- | |
| Cash From Financing | -- | -- | -- | -- | -- | |
| Free Cash Flow | -- | -- | -- | -- | -- | |
AKESF
Sector
Market Cap
$10.5B
$34.4M
Price % of 52-Week High
82.45%
44.25%
Dividend Yield
0%
0%
Shareholder Yield
-5.25%
-0.82%
1-Year Price Total Return
84.34%
-39.44%
Beta (5-Year)
--
0.738
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years
Technicals
8-day SMA
Sell
Level
$11.90
200-day SMA
Buy
Level
$7.93
Bollinger Bands (100)
Buy
Level
7.22 - 10.2
Chaikin Money Flow
Buy
Level
109.9K
20-day SMA
Buy
Level
$10.83
Relative Strength Index (RSI14)
Buy
Level
55.81
ADX Line
Buy
Level
29.63
Williams %R
Neutral
Level
-46.0316
50-day SMA
Buy
Level
$9.70
MACD (12, 26)
Buy
Level
0.88
25-day Aroon Oscillator
Buy
Level
52
On Balance Volume
Neutral
Level
689.8K
Financial Scores
--
Altman Z-Score
(Annual)
Level (--)
Sell
CA Score
(Annual)
Level (-0.4562)
Sell
Beneish M-Score
(Annual)
Level (0.8066)
Buy
Momentum Score
Level (10)
Buy
Ohlson Score
Level (-2.8495)
Sell
Piotroski F Score
(Annual)
Level (3)
--
Quality Ratio Score
Level (--)
--
Fundamental Score
Level (--)
Revenue Forecast
Earnings per Share Forecast
Company Profile
Akeso Inc is an investment holding company. The Company’s subsidiaries were involved in research and development, production, and commercialization of biopharmaceutical products. The company currently has a pipeline of over 30 drugs for the treatment of diseases like cancers, autoimmune diseases, inflammation, and metabolic diseases, 17 of which have entered the clinical stage, including two first-in-class bi-specific antibody drugs (PD-1/CTLA-4 and PD-1/VEGF). The majority of the company's revenue is earned in USA.
Stock Forecast FAQ
In the current month, AKESF has received 0 Buy ratings 0 Hold ratings, and 0 Sell ratings. The AKESF average analyst price target in the past 3 months is --.
-
Where Will Akeso Stock Be In 1 Year?
According to analysts, the consensus estimate is that Akeso share price will drop to -- per share over the next 12 months.
-
What Do Analysts Say About Akeso?
Analysts are divided on their view about Akeso share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Akeso is a Sell and believe this share price will rise from its current level to --.
-
What Is Akeso's Price Target?
The price target for Akeso over the next 1-year time period is forecast to be -- according to 0 Wall Street analysts, 0 of them rate the stock a Buy, 0 rate the stock a Sell, and 0 analysts rate the stock a Hold.
-
Is AKESF A Buy, Sell Or Hold?
According to Wall Street analysts, the consensus rating for Akeso is a --. 0 of 0 analysts rate the stock a -- at this time.
-
How Can I Buy Shares Of AKESF?
You can purchase shares of Akeso via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, tastytrade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Akeso shares.
-
What Is The Akeso Share Price Today?
Akeso was last trading at $11.30 per share. This represents the most recent stock quote for Akeso. Yesterday, Akeso closed at $11.65 per share.
-
How To Buy Akeso Stock Online?
In order to purchase Akeso stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is The Trade Desk the Best Advertising Stock Now?
The worldly backdrop is now shrouded in heavy uncertainty and…
Is it Too Late to Buy Gold?
Amid deep uncertainties about the future of the US economy,…
Stock Ideas
Buy
61
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
55
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 37x
Alerts
Sell
39
RGC alert for Apr 29
Regencell Bioscience Holdings [RGC] is down 11.18% over the past day.
Buy
76
EXOD alert for Apr 29
Exodus Movement [EXOD] is down 3.2% over the past day.
Sell
48
SBGSY alert for Apr 29
Schneider Electric SE [SBGSY] is down 0.17% over the past day.
